Largest biotech companies in the United States by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 20 biotech companies in the United States ranked by net assets, at SGD 29.3B, ahead of Biogen (SGD 23.5B) and Amgen (SGD 11.2B). Figures as of 20 Nov 2026, 07:46 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
20
First
Gilead SciencesSGD 29.3B
Median
SGD 2.1B
Combined market value
SGD 947.6B
Countries
1

Market values as of .

United States
All sectors
Biotech
SGD
Clear filters
Largest biotech companies in the United States by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CareSGD 29.3BSGD 266.3BSGD 214.72 1.45% down 35% up United States
2BiogenBIIB · Health CareSGD 23.5BSGD 47.1BSGD 318.64 1.70% down 49% up United States
3AmgenAMGN · Health CareSGD 11.2BSGD 306.1BSGD 565.81 1.14% down 32% up United States
4ModernaMRNA · Health CareSGD 11.2BSGD 104BSGD 257.01 1.29% up 780% up United States
5Neurocrine BiosciencesNBIX · Health CareSGD 4.2BSGD 20.4BSGD 201.90 3.85% down 17% up United States
6VaxcytePCVX · Health CareSGD 3.5BSGD 11.9BSGD 75.25 0.27% down 23% up United States
7ExelixisEXEL · Health CareSGD 2.8BSGD 20.7BSGD 84.88 3.60% down 63% up United States
8Bio-TechneTECH · Health CareSGD 2.7BSGD 14.7BSGD 93.74 0.07% down 24% up United States
9RepligenRGEN · Health CareSGD 2.7BSGD 14BSGD 219.57 1.38% down 12% up United States
10Revolution MedicinesRVMD · Health CareSGD 2.1BSGD 44.5BSGD 205.57 0.24% down 129% up United States
11Kymera TherapeuticsKYMR · Health CareSGD 2BSGD 13.1BSGD 153.94 1.44% down 87% up United States
12Krystal BiotechKRYS · Health CareSGD 1.6BSGD 12.1BSGD 407.21 0.15% up 54% up United States
13ImmunovantIMVT · Health CareSGD 1.1BSGD 8.7BSGD 41.93 1.96% down 46% up United States
14CG OncologyCGON · Health CareSGD 970.4MSGD 9.4BSGD 105.60 2.38% up 97% up United States
15Twist BioscienceTWST · Health CareSGD 609.8MSGD 9.8BSGD 143.92 4.07% down 346% up United States
16Scholar Rock HoldingSRRK · Health CareSGD 316.5MSGD 7.9BSGD 64.95 4.94% up 26% up United States
17Adaptive BiotechnologiesADPT · Health CareSGD 282.1MSGD 5.9BSGD 36.17 1.44% down 74% up United States
18Kodiak SciencesKOD · Health CareSGD 202.9MSGD 8.3BSGD 126.23 0.09% up 399% up United States
19Halozyme TherapeuticsHALO · Health CareSGD 62.9MSGD 13.7BSGD 119.96 2.88% down 39% up United States
20ImmunityBioIBRX · Health Care-SGD 645.3MSGD 9BSGD 8.47 1.94% down 232% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2894 SGD).

Questions and answers

Which biotech companies in the United States rank first by net assets?

Gilead Sciences (SGD 29.3B), Biogen (SGD 23.5B) and Amgen (SGD 11.2B) are the top three of the 20 biotech companies in the United States ranked by net assets as of 20 Nov 2026, 07:46 UTC.

How many biotech companies in the United States are in this ranking?

20 are ranked by net assets.

What are these biotech companies in the United States worth together?

The 20 biotech companies in the United States ranked by net assets have a combined market value of SGD 947.6B as of 20 Nov 2026, 07:46 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech companies in the United States by net assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.